Clinical Trials Logo

Clinical Trial Summary

Brain injury after spontaneous intracerebral hemorrhage results from pathophysiologic responses in the brain parenchyma due to hematoma formation, release of clot components, and surrounding edema. Inflammatory cascade activation in the perihematomal brain parenchyma has been implicated in the pathogenesis of secondary brain injury. Statins have been identified as a potential neuroprotective agent that targets the inflammatory response to intracerebral hemorrhage. In preclinical studies, statin treatment in animal intracerebral hemorrhage models has consistently demonstrated neuroprotective and recovery enhancement effects. Clinical investigations in humans reported better patient outcomes associated with statin use in patients with intracerebral hemorrhage, including reduced perihematomal edema, lower mortality rates, and improved functional outcomes.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT04857632
Study type Interventional
Source Capital Medical University
Contact Chuanjie Wu, Dr.
Phone 18911366882
Email [email protected]
Status Not yet recruiting
Phase Phase 2/Phase 3
Start date May 1, 2021
Completion date December 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Recruiting NCT04178746 - PRONTO: Artemis in the Removal of Intraventricular Hemorrhage in the Hyper-Acute Phase
Not yet recruiting NCT03956485 - Multicentre Registry of Patients With Spontaneous Acute Intracerebral Hemorrhage in Catalonia (HIC-CAT).
Enrolling by invitation NCT02920645 - Multicenter Validation of the AVICH Score N/A
Recruiting NCT02625948 - Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign Phase 2
Completed NCT02478177 - Addressing Real-world Anticoagulant Management Issues in Stroke
Completed NCT01971359 - Clinical Outcomes Following Parafascicular Surgical Evacuation of Intracerebral Hemorrhage: A Pilot Study N/A
Completed NCT01261091 - Early Tracheostomy in Ventilated Stroke Patients N/A
Terminated NCT00990509 - Albumin for Intracerebral Hemorrhage Intervention Phase 2
Completed NCT00716079 - The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial N/A
Recruiting NCT00222625 - rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets Phase 2
Recruiting NCT04548596 - NOninVasive Intracranial prEssure From Transcranial doppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients
Recruiting NCT04604587 - MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA Phase 3
Completed NCT02175225 - Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial Phase 2
Enrolling by invitation NCT01918722 - Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy Phase 4
Terminated NCT00718328 - Simvastatin For Intracerebral Hemorrhage Study Phase 2
Completed NCT00526214 - Administration of Celecoxib for Treatment of Intracerebral Hemorrhage : A Pilot Study N/A
Recruiting NCT04132115 - Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)
Active, not recruiting NCT03496545 - Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury Phase 1/Phase 2
Completed NCT03741530 - Glibenclamide Advantage in Treating Edema After Intracerebral Hemorrhage N/A